Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (NYSE: BHC)
    3. /

NYSE:BHC (Bausch Health Companies Inc.)

About BHC

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (NYSE: BHC) Latest News

    The Motley Fool
    Investing

    Is it Time to Say Goodbye to Valeant Pharmaceuticals Intl Inc.?

    | Jason Phillips

    After rising 92% earlier in the year, shares in Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) have cooled off. Is it time…

    Read more »

    The Motley Fool
    Investing

    When to Catch a Falling Knife: Shopify Inc.

    | Ryan Goldsman

    After pulling back, investors need to be extremely cautious with shares of Shopify Inc. (TSX:SHOP)(NYSE:SHOP).

    Read more »

    The Motley Fool
    Investing

    Where to Invest Before Canada Enters a Recession

    | Ryan Goldsman

    With things looking good in the economy, investors may want to buy shares of Canopy Growth Corp. (TSX:WEED), as they…

    Read more »

    Tech Stocks

    Is Shopify Inc. the Next Valeant Pharmaceuticals Intl Inc.?

    | Joey Frenette

    Shopify Inc. (TSX:SHOP)(NYSE:SHOP) shares plunged following Andrew Left's short thesis on the high-flying Canadian growth king. Should investors dump the…

    Read more »

    The Motley Fool
    Investing

    Is a $5 Billion Debt Reduction for Valeant Pharmaceuticals Intl Inc. Enough?

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is well on its way to meeting its goal for debt reduction, but is that…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Value Trap or Opportunity?

    | Demetris Afxentiou

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to come up as a potential investment option, but is that level of risk…

    Read more »

    The Motley Fool
    Investing

    Healthy Competition: Valeant Pharmaceuticals Intl Inc. vs. Jamieson Wellness Inc.

    | Ambrose O'Callaghan

    Canadians are spending more money on healthcare products as the population ages, but investors need to choose carefully between companies…

    Read more »

    calm, no emotion
    Investing

    Investing in Valeant Pharmaceuticals Intl Inc. Requires Immense Patience

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) got its short-term debt under control, but in a few years, it could become a problem…

    Read more »

    The Motley Fool
    Investing

    These 2 Pharma Giants Are Trading at Steep Discounts

    | Jason Phillips

    Healthcare stocks are up 21% since the start of the year, yet Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) and one…

    Read more »

    Investing

    The Top 4 Stocks to Short as Rates Continue to Rise

    | Ryan Goldsman

    With higher interest expenses, companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be the best short sell available.

    Read more »

    calm, no emotion
    Metals and Mining Stocks

    2 Turnaround Stocks Worth Considering

    | Demetris Afxentiou

    Cameco Corp. (TSX:CCO)(NYSE:CCJ) has dropped significantly over the past five years, but it is one of several stocks that still…

    Read more »

    The Motley Fool
    Investing

    4 Reasons Valeant Pharmaceuticals Intl Inc. Might Be a Good Investment Today

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is down over 20% in the past month and could present a great buying opportunity.

    Read more »